Compare Johnson & Johnson (JNJ) vs Progressive Corp (PGR) Price & Performance

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.

PGR trades at $208.28, down 2.65% on the day, with a bearish technical signal. The stock shows strong fundamentals with a P/E of 10.65, net income margin of 12.85%, and robust revenue growth from $49.6B in 2022 to $87.6B in 2025. Recent Q2 2026 earnings beat expectations at $4.85 EPS, though Q1 2026 missed. Analyst consensus is a buy with a $231.20 price target, but technical indicators suggest near-term caution.

Outlook remains positive due to solid profitability and growth, but risks include competitive pressures and potential margin compression. The stock offers value at current levels with upside to analyst targets, though investors should monitor execution on growth initiatives and industry dynamics.